Although considerable work is needed to delineate the exact role of IgM in warm AIHA and to explore its role as a key modulator of autoaggressive responses, the paradigm for treatment with immunotherapy approaches has formed on the basis of IgM pathophysiology. Here, CD40LG is linked to autoimmune hemolytic anemia.